- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04008303
Outcomes of Migraine Surgery
Outcomes of Following Surgical Decompression for the Treatment of Migraine
Migraines are very common and affect over 35 million Americans a year. Migraines can be painful and affect daily life. The cause of migraine is multifactorial and not completely understood. Treatment usually includes different classes of medications, life style changes, physical therapy, acupuncture, nerve stimulators and avoiding common triggers (like bright lights, certain foods, or loud sounds).
For some patients, Botox injected into the muscles of the forehead and neck can significantly reduce pain. Unfortunately, this does not provide long-term relief as the effect of Botox lasts for 3 months. Since year 2000 surgery to treat a selected population of migraine patients has been gaining popularity and showing promising results. The surgery reduces the pressure on the peripheral nerves that are believed to cause migraine headaches by resecting the surrounding tissue (bone, fascia, muscle, and arteries). This surgery provides a more long-term and permanent relief.
The purpose of this study is to follow the effectiveness and outcomes of migraine surgery.
Study Overview
Detailed Description
Migraines are very common and affect over 35 million Americans a year. Migraines can be painful and affect daily life. The cause of migraine is multifactorial and not completely understood. Treatment usually includes different classes of medications, life style changes, physical therapy, acupuncture, nerve stimulators and avoiding common triggers (like bright lights, certain foods, or loud sounds).
For some patients, Botox injected into the muscles of the forehead and neck can significantly reduce pain. Unfortunately, this does not provide long-term relief as the effect of Botox lasts for 3 months. Since year 2000 surgery to treat a selected population of migraine patients has been gaining popularity and showing promising results. The surgery reduces the pressure on the peripheral nerves that are believed to cause migraine headaches by resecting the surrounding tissue (bone, fascia, muscle, and arteries). This surgery provides a more long-term and permanent relief.
The purpose of this study is to follow the effectiveness and outcomes of migraine surgery.
Study Type
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years or older
- Cleared by neurology and headache specialists for surgery
- Patient cleared by neurology for not having medication overuse headaches
- Patient able to localize a consistent trigger site where the migraines start
- Patient has been suffering from migraine for more than 2 years
- Botox injections or nerve blocks have worked for migraine relief in the past
- Patients formally diagnosed with migraine headaches by a neurologist
- Migraines impact quality of life per MIDAS survey
- No history of Mania, Bipolar disorder, Major Dispersive disorder, or suicidal ideation
Exclusion Criteria:
- High dose opioid medication use
- Does not meet criteria for migraine diagnosis
- History of prior surgery for migraines
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with migraines
Patients seen in clinic and assessed with Migraine Headache Diagnostic Criteria to ensure diagnosis. Patients track the characteristics of migraine headaches for one month before surgery. After this month, patients receive surgery in the operating room for migraine. After surgery, patients track the characteristics of migraine headaches for 3 months. Patients will then be asked to track the characteristics migraine headaches again at 1 year and 2 years and 5 years after surgery. For these time periods, patients only have to keep track of the characteristics for 1 month intervals. |
Surgical decompression of neuromuscular structures causing migraine headaches.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Frequency
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Frequency
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Duration
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Duration -How long the migraine headaches last in minutes |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Location
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Location
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Quality
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Quality
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Severity
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Severity - Migraine headache severity graded on a 0-10 scale, with 10 being the most severe. |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Laterality
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Laterality
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Associated Symptoms
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Associated symptoms
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Exacerbating factors
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Exacerbating factors
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
|
Change in International Classification of Headache Disorders Diagnostic criteria: Relieving factors
Time Frame: 1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Relieving factors
|
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
|
Collaborators and Investigators
Investigators
- Study Director: Salam Kassis, MD, Vanderbilt University Medical Center
Publications and helpful links
General Publications
- Negro A, Rocchietti-March M, Fiorillo M, Martelletti P. Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1401-20.
- Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014 Oct;134(4 Suppl 2):131S-141S. doi: 10.1097/PRS.0000000000000661.
- Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol. 1995 Feb;48(2):269-80. doi: 10.1016/0895-4356(94)00128-d.
- Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec;6(6):429-40. doi: 10.1007/s10194-005-0252-4. Epub 2005 Dec 15.
- Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011 Feb;127(2):603-608. doi: 10.1097/PRS.0b013e3181fed456.
- Gfrerer L, Guyuron B. Surgical treatment of migraine headaches. Acta Neurol Belg. 2017 Mar;117(1):27-32. doi: 10.1007/s13760-016-0731-1. Epub 2016 Dec 24.
- Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009 Aug;124(2):461-468. doi: 10.1097/PRS.0b013e3181adcf6a.
- Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000 Aug;106(2):429-34; discussion 435-7. doi: 10.1097/00006534-200008000-00030.
- Lee M, Monson MA, Liu MT, Reed D, Guyuron B. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg. 2013 Apr;131(4):751-757. doi: 10.1097/PRS.0b013e3182818b7f.
- Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005 Jan;115(1):1-9.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 190993
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Brigham and Women's HospitalNot yet recruitingMigraine Disorders | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
CoolTech LLCTerminatedMigraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Tonix Pharmaceuticals, Inc.PremierCompletedChronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura MigraineUnited States
-
Notre-Dame Hospital, Montreal, Quebec, CanadaAllerganCompletedChronic Migraine | Migraine Without Aura | Migraine With AuraCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraDenmark
-
Fundación de Investigación Biomédica - Hospital...Hospital Universitario La Fe; Hospital Vall d'Hebron; Hospital Universitario... and other collaboratorsRecruitingMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraSpain
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...CompletedMigraine With Aura | Migraine in ChildrenItaly
Clinical Trials on Migraine surgery
-
IRCCS National Neurological Institute "C. Mondino...Completed
-
Karolinska University HospitalCompleted
-
Wake Forest University Health SciencesNational Center for Complementary and Integrative Health (NCCIH)Recruiting
-
Children's Hospital Medical Center, CincinnatiActive, not recruiting
-
University of Colorado, DenverChildren's Hospital ColoradoCompletedMigraine | Migraine in AdolescenceUnited States
-
University of GaziantepCompleted
-
Eli Lilly and CompanyWake Forest University Health SciencesCompleted
-
TheranicaCompleted
-
Scion NeuroStimTerminatedInterventionUnited States, United Kingdom
-
Norwegian University of Science and TechnologyRecruiting